37 results
8-K
GMDAQ
Gamida Cell Ltd
20 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
Officer. The votes were cast as follows:
Votes For
VotesAgainst
Abstained
CEO Compensation Package and Special Bonus
Broker Non-Votes: 19,950,804
8-K
EX-1.1
au3nkweopghy6mn
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.1
fubpygz8290hbitsn7z
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
8-K
EX-10.1
yz18776b16it a4
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-1.1
4qjmjojuus69n946n
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
DEF 14A
z1iu wty1w0czfw
22 Jun 22
Definitive proxy
4:22pm
PRE 14A
t6r6ywzh
10 Jun 22
Preliminary proxy
4:25pm
10-K
pllc17c32
24 Mar 22
Annual report
7:30am
6-K
EX-4.1
lt92nh2xh9azi
16 Feb 21
Gamida Cell Announces $75 Million Financing with Highbridge Capital Management
8:57am
6-K
EX-1.1
gefhryhdl69p1
21 Dec 20
Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares
4:38pm
6-K
EX-1.1
b919le
20 May 20
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
4:14pm